Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes.

Lamorte L, Titolo S, Lemke CT, Goudreau N, Mercier JF, Wardrop E, Shah VB, von Schwedler UK, Langelier C, Banik SS, Aiken C, Sundquist WI, Mason SW.

Antimicrob Agents Chemother. 2013 Oct;57(10):4622-31. doi: 10.1128/AAC.00985-13. Epub 2013 Jul 1.

2.

Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.

Lemke CT, Titolo S, von Schwedler U, Goudreau N, Mercier JF, Wardrop E, Faucher AM, Coulombe R, Banik SS, Fader L, Gagnon A, Kawai SH, Rancourt J, Tremblay M, Yoakim C, Simoneau B, Archambault J, Sundquist WI, Mason SW.

J Virol. 2012 Jun;86(12):6643-55. doi: 10.1128/JVI.00493-12. Epub 2012 Apr 11.

3.

NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains.

Chung HY, Morita E, von Schwedler U, Müller B, Kräusslich HG, Sundquist WI.

J Virol. 2008 May;82(10):4884-97. doi: 10.1128/JVI.02667-07. Epub 2008 Mar 5.

4.

Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release.

Langelier C, von Schwedler UK, Fisher RD, De Domenico I, White PL, Hill CP, Kaplan J, Ward D, Sundquist WI.

J Virol. 2006 Oct;80(19):9465-80.

5.

Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid.

Hatziioannou T, Cowan S, Von Schwedler UK, Sundquist WI, Bieniasz PD.

J Virol. 2004 Jun;78(11):6005-12.

6.

Assembly properties of the human immunodeficiency virus type 1 CA protein.

Ganser-Pornillos BK, von Schwedler UK, Stray KM, Aiken C, Sundquist WI.

J Virol. 2004 Mar;78(5):2545-52.

7.

The protein network of HIV budding.

von Schwedler UK, Stuchell M, Müller B, Ward DM, Chung HY, Morita E, Wang HE, Davis T, He GP, Cimbora DM, Scott A, Kräusslich HG, Kaplan J, Morham SG, Sundquist WI.

Cell. 2003 Sep 19;114(6):701-13.

8.

Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

von Schwedler UK, Stray KM, Garrus JE, Sundquist WI.

J Virol. 2003 May;77(9):5439-50.

9.

Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication.

Forshey BM, von Schwedler U, Sundquist WI, Aiken C.

J Virol. 2002 Jun;76(11):5667-77.

10.

Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Côté M, Rich RL, Myszka DG, Sundquist WI.

Cell. 2001 Oct 5;107(1):55-65.

11.

A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidine.

Smith RA, Klarmann GJ, Stray KM, von Schwedler UK, Schinazi RF, Preston BD, North TW.

Antimicrob Agents Chemother. 1999 Aug;43(8):2077-80.

12.

Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.

von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, Sundquist WI.

EMBO J. 1998 Mar 16;17(6):1555-68. Erratum in: EMBO J 2000 May 15;19(10):2391.

13.

Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.

Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, Wang H, McCutcheon JP, Sundquist WI, Hill CP.

Science. 1997 Oct 31;278(5339):849-53.

14.

Retroviral-mediated expression of FIV envelope/Rev induces CD8+ CTL responses in mice.

von Schwedler U, Townsend K, Chada S, Jolly DJ, Elder J, Chang SM, Lee WT.

Intervirology. 1997;40(4):271-6.

PMID:
9612729
16.

Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.

von Schwedler U, Song J, Aiken C, Trono D.

J Virol. 1993 Aug;67(8):4945-55.

17.

Beswitched. The looping out model for immunoglobulin class switching.

von Schwedler U, Jäck HM, Wabl M.

New Biol. 1990 Aug;2(8):657-62. Review.

PMID:
2282364
18.

Circular DNA is a product of the immunoglobulin class switch rearrangement.

von Schwedler U, Jäck HM, Wabl M.

Nature. 1990 May 31;345(6274):452-6.

PMID:
2111465

Supplemental Content

Loading ...
Support Center